From molecule to man: Integrating molecular biology with whole organ physiology in studying respiratory disease

Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift


Chronic lung diseases such as asthma, chronic obstructive pulmonary disease (COPD), and idiopathic pulmonary fibrosis (IPF) are all characterized by structural changes of the airways and/or lungs that limit airflow and/or gas exchange. Currently, there is no therapy available that adequately targets the structural remodeling of the airways and lungs in these diseases. This underscores the great need for insight into the mechanisms that underpin the development of airway remodeling, fibrosis and emphysema in these diseases, in order to identify suitable drug targets. It is increasingly evident that structural cell-cell communication within the lung is central to the development of remodeling, indicating that a more integrative approach should be considered when studying molecular and cellular mechanisms of remodeling. Therefore, there is a great need to study molecular and cellular physiological and pathophysiological mechanisms in as much detail as possible, but with as little as possible loss of the physiological context. Here, we will review the use of models such as cellular co-culture, tissue culture, and lung slice culture, in which cell-cell communication and tissue architecture are better preserved or mimicked than in cell culture, and zoom in on the usefulness of molecular and cellular biological tools in these complex model systems to read out or control signaling and gene/protein regulation.


Externa organisationer
  • Ludwig-Maximilian University of Munich
  • Helmholtz Zentrum München


Sidor (från-till)466-470
Antal sidor5
TidskriftPulmonary Pharmacology and Therapeutics
StatusPublished - 2011 okt 1
Peer review utfördJa
Externt publiceradJa